The use of abciximab in coronary angioplasty - An Asian centre's experience
Singapore Medical Journal
Saved in:
Main Authors: | Tan, H.C., Lim, Y.T., Lim, T.T., Chia, B.L., Cheng, A. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117929 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Fatal pulmonary haemorrhage with the combined use of abciximab and fibrinolytic agent
by: Tan, H.C., et al.
Published: (2014) -
Fatal pulmonary haemorrhage with the combined use of abciximab and fibrinolytic agent
by: Tan, H.C., et al.
Published: (2016) -
ReoPro Observational Registry (RAPOR): Insights from the multicentre use of abciximab in Asia
by: Poh, K.K., et al.
Published: (2016) -
Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study
by: Wong, A., et al.
Published: (2016) -
The impact of time-to-balloon on outcomes in patients undergoing modern primary angioplasty for acute myocardial infarction
by: Soon, C.Y., et al.
Published: (2016)